JPS5698201A - Controlled release composition - Google Patents

Controlled release composition

Info

Publication number
JPS5698201A
JPS5698201A JP17962980A JP17962980A JPS5698201A JP S5698201 A JPS5698201 A JP S5698201A JP 17962980 A JP17962980 A JP 17962980A JP 17962980 A JP17962980 A JP 17962980A JP S5698201 A JPS5698201 A JP S5698201A
Authority
JP
Japan
Prior art keywords
controlled release
release composition
composition
controlled
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP17962980A
Other languages
English (en)
Other versions
JPH0225921B2 (ja
Inventor
Tomasu Rezurii Suchiyuaato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Publication of JPS5698201A publication Critical patent/JPS5698201A/ja
Publication of JPH0225921B2 publication Critical patent/JPH0225921B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/05—Alcohols; Metal alcoholates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP17962980A 1979-12-19 1980-12-18 Controlled release composition Granted JPS5698201A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE2480/79A IE49324B1 (en) 1979-12-19 1979-12-19 Controlled release compositions
IE248179 1979-12-19

Publications (2)

Publication Number Publication Date
JPS5698201A true JPS5698201A (en) 1981-08-07
JPH0225921B2 JPH0225921B2 (ja) 1990-06-06

Family

ID=26319271

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17962980A Granted JPS5698201A (en) 1979-12-19 1980-12-18 Controlled release composition

Country Status (27)

Country Link
US (1) US4366310A (ja)
EP (1) EP0032004B1 (ja)
JP (1) JPS5698201A (ja)
AU (1) AU541246B2 (ja)
BE (1) BE886711A (ja)
CA (1) CA1168230A (ja)
CS (1) CS228142B2 (ja)
DE (1) DE3048028A1 (ja)
DK (1) DK170347B1 (ja)
EG (1) EG14984A (ja)
ES (1) ES497906A0 (ja)
FI (1) FI66623C (ja)
FR (1) FR2474507B1 (ja)
GB (1) GB2067569B (ja)
GR (1) GR72265B (ja)
HU (1) HU188085B (ja)
IE (1) IE49324B1 (ja)
IL (1) IL61677A (ja)
MX (1) MX158088A (ja)
NL (1) NL187401C (ja)
NO (1) NO152846C (ja)
NZ (1) NZ195793A (ja)
PL (1) PL133079B1 (ja)
PT (1) PT72214B (ja)
SU (1) SU1178326A3 (ja)
YU (1) YU40957B (ja)
ZA (1) ZA807716B (ja)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61286321A (ja) * 1985-06-11 1986-12-16 ユ−ロセルテイツク・エス・ア− 口腔又は鼻腔用医薬組成物
JPS62292720A (ja) * 1986-06-10 1987-12-19 ユ−ロセルテイツク・エス・ア− 制御放出型ジヒドロコデイン組成物
JPS63122623A (ja) * 1986-10-31 1988-05-26 ユーロセルテイツク・エス・アー 徐放性ヒドロモルホン組成物
JP2010159364A (ja) * 2009-01-09 2010-07-22 Kyoto Univ セルロースの高温での着色を抑制する方法
JP2013526509A (ja) * 2010-05-10 2013-06-24 ユーロ−セルティーク エス．エイ． 活性剤を含まない顆粒およびその顆粒を含む錠剤の製造

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1211266A (en) * 1982-11-12 1986-09-16 Alfred E. Lauchenauer Shaped semi-solid articles
DE3306621A1 (de) * 1983-02-25 1984-08-30 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von celluloseethern mit einem dimethoxyethan enthaltenden dispergierhilfsmittel
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
US5079005A (en) * 1988-06-17 1992-01-07 Gupta Kashmiri L Time release protein
US5023080A (en) * 1988-06-17 1991-06-11 Basic Bio Systems, Inc. Time release protein
US5055300A (en) * 1988-06-17 1991-10-08 Basic Bio Systems, Inc. Time release protein
US5476668A (en) * 1990-08-24 1995-12-19 Shin-Etsu Chemical Co., Ltd. Base for film-coating pharmaceuticals and method for preparing same
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
WO1998056359A2 (de) * 1997-06-13 1998-12-17 Roland Bodmeier Zusammensetzungen, die die wirkstofffreisetzung verzögern
EP1041987B1 (en) 1997-12-22 2006-04-19 Euro-Celtique S.A. Pharmaceutical oral dosage form comprising a combination of an opioid agonist and naltrexone
EP2092936B1 (en) 2000-02-08 2013-03-20 Euro-Celtique S.A. Tamper-resistant oral opioid agonist formulations
EP1387673B1 (en) 2001-05-11 2010-12-29 Endo Pharmaceuticals Inc. Abuse-resistant controlled-release opioid dosage form
SI1416842T1 (sl) 2001-07-18 2009-06-30 Euro Celtique Sa Farmacevtske kombinacije oksikodona in naloksona
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US20030157168A1 (en) 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
IL160222A0 (en) * 2001-08-06 2004-07-25 Euro Celtique Sa Opioid agonist formulations with releasable and sequestered antagonist
HUE032656T2 (en) 2002-04-05 2017-10-30 Euro Celtique Sa Pharmaceutical composition containing oxicodone and naloxone
CN1703200B (zh) 2002-09-20 2012-02-29 奥尔制药公司 隔离亚单元和相关组合物及方法
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
MY135852A (en) 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
PT1765292T (pt) 2004-06-12 2017-12-29 Collegium Pharmaceutical Inc Formulações de fármacos dissuasoras de abuso
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
SI2719378T1 (sl) 2006-06-19 2016-11-30 Alpharma Pharmaceuticals Llc Farmacevtski sestavki
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
SG174286A1 (en) 2009-03-10 2011-10-28 Euro Celtique Sa Immediate release pharmaceutical compositions comprising oxycodone and naloxone
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CN103002881B (zh) 2010-05-10 2015-09-02 欧洲凯尔特公司 载有活性剂的颗粒与额外活性剂的组合
AU2011252039B2 (en) 2010-05-10 2014-06-12 Euro-Celtique S.A. Pharmaceutical compositions comprising hydromorphone and naloxone
HUE034955T2 (en) 2010-12-22 2018-03-28 Purdue Pharma Lp Encased tamper resistant controlled release dosage forms
PH12013501345A1 (en) 2010-12-23 2022-10-24 Purdue Pharma Lp Tamper resistant solid oral dosage forms
MX2015010041A (es) 2013-02-05 2015-10-30 Purdue Pharma Lp Formulacion farmaceuticas resistentes a la alteracion.
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
JP2016525138A (ja) 2013-07-23 2016-08-22 ユーロ−セルティーク エス．エイ． 疼痛および腸内ディスバイオシスをもたらす疾患および／または腸内細菌移行に対するリスクを高める疾患に罹患している患者における痛みの治療への使用のためのオキシコドンおよびナロキソンの組み合わせ
WO2015071380A1 (en) 2013-11-13 2015-05-21 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264766A (en) * 1877-09-19 1981-04-28 Hoffmann-La Roche Inc. Immunological diagnostic reagents
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
GB1405088A (en) * 1971-06-03 1975-09-03 Mundipharma Ag Slow release formulation
US3988482A (en) * 1971-08-27 1976-10-26 Toyo Hakka Kogyo Kabushiki Kaisha Menthol glycoside, process for preparing the same and method for releasing menthol therefrom
US3818107A (en) * 1972-09-28 1974-06-18 Brook D Chewing gum with sustained flavor release compositions
US3899439A (en) * 1973-03-12 1975-08-12 Hercules Inc Method of preparing aqueous dispersions of hydroxypropyl cellulose
DE2644678A1 (de) * 1976-10-02 1978-04-06 Dynamit Nobel Ag Verfahren zur herstellung funktionalisierter cellulosen
JPS54105223A (en) * 1977-12-29 1979-08-18 Yamanouchi Pharmaceut Co Ltd Coating agent for solid medicine
US4259355A (en) * 1979-03-05 1981-03-31 International Flavors & Fragrances Inc. Chewing gum containing flavor composition and flavor composition therefor
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61286321A (ja) * 1985-06-11 1986-12-16 ユ−ロセルテイツク・エス・ア− 口腔又は鼻腔用医薬組成物
JPS62292720A (ja) * 1986-06-10 1987-12-19 ユ−ロセルテイツク・エス・ア− 制御放出型ジヒドロコデイン組成物
JPS63122623A (ja) * 1986-10-31 1988-05-26 ユーロセルテイツク・エス・アー 徐放性ヒドロモルホン組成物
JP2010159364A (ja) * 2009-01-09 2010-07-22 Kyoto Univ セルロースの高温での着色を抑制する方法
JP2013526509A (ja) * 2010-05-10 2013-06-24 ユーロ−セルティーク エス．エイ． 活性剤を含まない顆粒およびその顆粒を含む錠剤の製造

Also Published As

Publication number Publication date
US4366310A (en) 1982-12-28
NO152846C (no) 1985-11-27
EP0032004B1 (en) 1985-05-15
IE49324B1 (en) 1985-09-18
FR2474507B1 (fr) 1986-12-26
JPH0225921B2 (ja) 1990-06-06
IL61677A (en) 1984-10-31
FI66623C (fi) 1984-11-12
NL187401B (nl) 1991-04-16
GR72265B (ja) 1983-10-10
DK170347B1 (da) 1995-08-07
GB2067569B (en) 1983-09-01
ZA807716B (en) 1981-12-30
PL133079B1 (en) 1985-05-31
YU321080A (en) 1983-06-30
EG14984A (en) 1986-06-30
IL61677A0 (en) 1981-01-30
NO152846B (no) 1985-08-19
CS228142B2 (en) 1984-05-14
MX158088A (es) 1989-01-06
NZ195793A (en) 1982-09-14
NL8006891A (nl) 1981-07-16
FI803848L (fi) 1981-06-20
PT72214B (en) 1981-11-02
PT72214A (en) 1980-08-01
HUT34891A (en) 1985-05-28
BE886711A (fr) 1981-06-17
FR2474507A1 (fr) 1981-07-31
AU541246B2 (en) 1985-01-03
YU40957B (en) 1986-08-31
DE3048028A1 (de) 1981-09-10
DK527680A (da) 1981-08-05
PL228573A1 (ja) 1982-07-19
NO803836L (no) 1981-06-22
EP0032004A2 (en) 1981-07-15
SU1178326A3 (ru) 1985-09-07
HU188085B (en) 1986-03-28
IE792480L (en) 1981-06-19
EP0032004A3 (en) 1982-07-14
ES8303489A1 (es) 1983-02-01
NL187401C (nl) 1991-09-16
GB2067569A (en) 1981-07-30
CA1168230A (en) 1984-05-29
AU6529880A (en) 1981-06-25
ES497906A0 (es) 1983-02-01
FI66623B (fi) 1984-07-31

Similar Documents

Publication Publication Date Title
JPS5698201A (en) Controlled release composition
GB2059764B (en) Controlled release formulations
GB2046283B (en) Soloxane composition
GB2056278B (en) Sustained release compositions
JPS565899A (en) Claning composition
AU520409B2 (en) Controlled release composition
GB2057420B (en) Controlled release glass
JPS5634751A (en) Polycarbonateepolyolefin composition
JPS55129447A (en) Composition
JPS5642229A (en) New photooresist composition
JPS5676402A (en) Thermosettable composition
JPS5682839A (en) Waterrabsorbable composition
GB2059766B (en) Controlled release formulations
JPS565406A (en) Tickicidal composition
JPS5691075A (en) Size composition
JPS55129229A (en) Indiumm1111oxine complex composition
GB2063348B (en) Release mechanism
EG14375A (en) Controlled release granules
JPS5622734A (en) Composition
JPS5649747A (en) Ureaaformaldehyde composition
JPS56135531A (en) Composition
JPS55118957A (en) Flameeproof composition
JPS569272A (en) Refractory composition
JPS565379A (en) Refractory composition
GB2058034B (en) Fluocculant composition